UroGen Pharma says permanent J Code for ZUSDURI now in effect

UroGen Pharma (URGN) announced that adult patients living with recurrent low-grade intermediate-risk non-muscle invasive ...
Seeking Alpha

Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3L

FLORHAM PARK, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative medicine company developing placental-derived allogeneic cell therapies and ...
Becker's ASC

ASCs brace for impact of Medicaid cuts

Medicaid is under scrutiny as Republican lawmakers eye big healthcare budget cuts for this year. Five ASC leaders joined Becker’s to discuss how they’re preparing for these cuts. Question: With ...
Medscape

Insurance Payment Policies May Drive Diagnoses for Medicaid Patients

Medicaid patients admitted to hospitals with a larger proportion of private payers received more diagnoses on Medicaid insurance claims than those in hospitals with a lower proportion of private ...
Nasdaq

Celularity Receives Healthcare Common Procedure Coding System (HCPCS) Q Code Approval from the U.S. Centers for Medicare & Medicaid Services for Biovance® 3L

Nationally Established Q Code Will Further Support the Use of Biovance® 3L by Physicians to Treat Wound Care Patients in Office Settings FLORHAM PARK, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- ...